XML 20 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Treasury stock
Retained earnings
Retained earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated other comprehensive loss
Cumulative effect adjustment for adoption of new accounting pronouncements (1) [1]           $ (1,077)  
Beginning of period (in shares) at Sep. 28, 2019   29,004,000          
Exercise of stock options and vesting of other share-based awards   608,000          
Treasury shares purchased (in shares)   (610,000)          
End of period (in shares) at Oct. 03, 2020   29,002,000          
Beginning of period at Sep. 28, 2019 $ 865,576 $ 529 $ 597,401 $ (893,247) $ 1,178,677   $ (17,784)
Exercise of stock options and vesting of other share-based awards   6          
Share-based compensation expense     24,280        
Exercise of stock options and vesting of other share-based awards, including tax withholding     (117)        
Treasury shares purchased       (41,392)      
Net income 117,479       117,479    
Other comprehensive (loss) income 12,725           12,725
End of period at Oct. 03, 2020 $ 977,480 $ 535 621,564 (934,639) 1,295,079   (5,059)
Exercise of stock options and vesting of other share-based awards   323,000          
Treasury shares purchased (in shares)   (1,278,000)          
End of period (in shares) at Oct. 02, 2021 28,047,000 28,047,000          
Exercise of stock options and vesting of other share-based awards   $ 3          
Share-based compensation expense     24,326        
Exercise of stock options and vesting of other share-based awards, including tax withholding     (6,112)        
Treasury shares purchased       (108,452)      
Net income $ 138,912       138,912    
Other comprehensive (loss) income 2,075           2,075
End of period at Oct. 02, 2021 $ 1,028,232 $ 538 639,778 (1,043,091) 1,433,991   (2,984)
Exercise of stock options and vesting of other share-based awards   235,000          
Treasury shares purchased (in shares)   (603,000)          
End of period (in shares) at Oct. 01, 2022 27,679,000 27,679,000          
Exercise of stock options and vesting of other share-based awards   $ 3          
Share-based compensation expense     23,377        
Exercise of stock options and vesting of other share-based awards, including tax withholding     (10,688)        
Treasury shares purchased       (50,392)      
Net income $ 138,243       138,243    
Other comprehensive (loss) income (33,044)           (33,044)
End of period at Oct. 01, 2022 $ 1,095,731 $ 541 $ 652,467 $ (1,093,483) $ 1,572,234   $ (36,028)
[1] See Note 1, "Description of Business and Significant Accounting Policies," for a discussion of recently adopted accounting pronouncements.